<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2018.6402</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-6402</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Preserving hepatic artery flow during portal triad blood occlusion improves regeneration of the remnant liver in rats with obstructive jaundice following partial hepatectomy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Kong</surname><given-names>Zhe</given-names></name>
<xref rid="af1-etm-0-0-6402" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Jian-Jun</given-names></name>
<xref rid="af2-etm-0-0-6402" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Ge</surname><given-names>Xin-Lan</given-names></name>
<xref rid="af1-etm-0-0-6402" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Pan</surname><given-names>Ke</given-names></name>
<xref rid="af1-etm-0-0-6402" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Chong-Hui</given-names></name>
<xref rid="af1-etm-0-0-6402" ref-type="aff">1</xref>
<xref rid="c1-etm-0-0-6402" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Dong</surname><given-names>Jia-Hong</given-names></name>
<xref rid="af3-etm-0-0-6402" ref-type="aff">3</xref>
<xref rid="c2-etm-0-0-6402" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-6402"><label>1</label>Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, Beijing 100853, P.R. China</aff>
<aff id="af2-etm-0-0-6402"><label>2</label>Former Outpatient Department for Bureau of Information Communication, Agency for Offices Administration, Central Military Commission, Beijing 100840, P.R. China</aff>
<aff id="af3-etm-0-0-6402"><label>3</label>Center for Hepatopancreatobiliary Diseases, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-6402"><italic>Correspondence to</italic>: Dr Chong-Hui Li, Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, 28 Fuxing Road, Beijing 100853, P.R. China, E-mail: <email>lich_plagh@163.com</email></corresp>
<corresp id="c2-etm-0-0-6402">Professor Jia-Hong Dong, Center for Hepatopancreatobiliary Diseases, Beijing Tsinghua Changgung Hospital, Tsinghua University, 168 Litang Road, Beijing 102218, P.R. China, E-mail: <email>dongjiahong@mail.tsinghua.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>09</month>
<year>2018</year></pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>07</month>
<year>2018</year></pub-date>
<volume>16</volume>
<issue>3</issue>
<fpage>1910</fpage>
<lpage>1918</lpage>
<history>
<date date-type="received"><day>30</day><month>11</month><year>2017</year></date>
<date date-type="accepted"><day>25</day><month>05</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Kong et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>In certain cases, major hepatectomy is essential and inevitable in patients with hilar cholangiocarcinoma and obstructive jaundice (OJ). The current study was designed to evaluate effects of a novel method of portal blood occlusion, where the portal vein was occluded (OPV) and the hepatic artery flow was preserved in rats with OJ that underwent partial hepatectomy. OJ was induced in rats by ligation of the common bile duct for 7 days. Subsequently, OJ rats underwent hepatectomy removing 76&#x0025; of the liver following occlusion of the portal triad (OPT), OPV or without portal blood occlusion. Liver blood flow (LBF), liver damage and regeneration were assessed. The safety limit for the duration of liver ischemia was 20 min for OPT and 40 min for OPV in rats with OJ. OPT and OPV methods resulted in significantly decreased microvascular LBF in rats with OJ from 529.53&#x00B1;91.55 laser speckle perfusion units (LSPU) in the control to 136.89&#x00B1;32.32 and 183.99&#x00B1;49.25 LSPU, respectively. Liver damage was assessed analyzing levels of serum alanine transaminase and direct bilirubin, determining interleukin-1&#x03B2; and tumor necrosis factor-&#x03B1; expression and histological examination. It was demonstrated that liver damage and caspase-3 and &#x2212;9 expression in the liver were substantially reduced in the OPV group compared with the OPT group. In addition, the OPV method significantly improved liver regeneration in OJ rats, as indicated by increased rates of liver regeneration and expression of proliferating cell nuclear antigen and Ki-67 compared with the OPT group. Therefore, the OPV method may prolong the duration of portal blood occlusion, reduce liver injury and improve liver regeneration by preserving hepatic arterial flow during portal blood control in rats with OJ undergoing partial hepatectomy. The current study describes a novel technique, which may be applied in liver surgery in patients with complex jaundice.</p>
</abstract>
<kwd-group>
<kwd>obstructive jaundice</kwd>
<kwd>hepatectomy</kwd>
<kwd>portal occlusion</kwd>
<kwd>laser speckle contrast imaging</kwd>
<kwd>hepatic artery</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Obstructive jaundice (OJ) is a common clinical symptom in cholangiocarcinoma and pancreatic cancer, which usually impairs liver function and reduces the regenerative capacity of liver (<xref rid="b1-etm-0-0-6402" ref-type="bibr">1</xref>). Pathological changes resulting from OJ, including cholangitis, cholestatic liver injury and digestive disorders, may exhibit adverse effects on surgical outcomes (<xref rid="b2-etm-0-0-6402" ref-type="bibr">2</xref>). However, major hepatectomy is essential and inevitable in a number of patients, particularly in those with hilar cholangiocarcinoma and OJ. The degree of ischemia-reperfusion (I/R) injury and the function of the remnant liver have been key focuses during hepatectomy and are associated with post-operative morbidity and mortality (<xref rid="b3-etm-0-0-6402" ref-type="bibr">3</xref>). I/R injury induces formation of reactive oxygen species that cause oxidative stress and cell death, ultimately leading to a sterile inflammatory response that causes hepatocellular damage and liver dysfunction that can result in acute liver failure in most severe cases (<xref rid="b4-etm-0-0-6402" ref-type="bibr">4</xref>). The current treatment strategy is to perform biliary drainage prior to surgery and to minimize the scale of the surgical procedure (<xref rid="b1-etm-0-0-6402" ref-type="bibr">1</xref>). However, the outcome is not favorable. Systematic review and meta-analysis have revealed that preoperative biliary drainage was associated with increased postoperative morbidity and wound infection (<xref rid="b5-etm-0-0-6402" ref-type="bibr">5</xref>). As previously established, using a suitable method for the occlusion of hepatic blood inflow has a marked effect in reducing blood loss and alleviating liver damage following liver resection (<xref rid="b4-etm-0-0-6402" ref-type="bibr">4</xref>). The current study hypothesized that the method of occlusion of hepatic blood inflow affects the outcomes of hepatectomy in patients with OJ.</p>
<p>The Pringle maneuver, occlusion of the portal triad (OPT), has been acknowledged for its ability in reducing blood loss during liver resection, and severe I/R injury is inevitable if the operation is complicated and prolonged occlusion is required (<xref rid="b6-etm-0-0-6402" ref-type="bibr">6</xref>,<xref rid="b7-etm-0-0-6402" ref-type="bibr">7</xref>). In addition, it has been demonstrated that the icteric liver exhibits reduced tolerance for I/R injury (<xref rid="b8-etm-0-0-6402" ref-type="bibr">8</xref>,<xref rid="b9-etm-0-0-6402" ref-type="bibr">9</xref>). However, the majority of cholangiocarcinoma cases coexist with OJ (<xref rid="b10-etm-0-0-6402" ref-type="bibr">10</xref>). At present, numerous occlusion strategies, including selective hemihepatic vascular occlusion, step-by-step vascular control and ischemic preconditioning have been designed to control the liver portal blood and reduce I/R injury (<xref rid="b11-etm-0-0-6402" ref-type="bibr">11</xref>&#x2013;<xref rid="b13-etm-0-0-6402" ref-type="bibr">13</xref>). A method for occlusion of the portal vein (OPV), while preserving hepatic artery blood flow during liver surgery was initially proposed and was demonstrated to be effective in a rat model of normothermic liver I/R (<xref rid="b14-etm-0-0-6402" ref-type="bibr">14</xref>). Although partial hepatectomy is a good model for liver regeneration, the liver injury induced by predisposed OJ and operation-related I/R may lead to suppressed liver regeneration (<xref rid="b7-etm-0-0-6402" ref-type="bibr">7</xref>&#x2013;<xref rid="b9-etm-0-0-6402" ref-type="bibr">9</xref>). Proliferating cell nuclear antigen (PCNA) and Ki-67 labeling indexes are two nuclear antigens associated with hepatocyte proliferation, which are often used to characterize the hepatic regenerative response (<xref rid="b15-etm-0-0-6402" ref-type="bibr">15</xref>). The current study was designed to evaluate the protective degree of OPV on the liver regeneration of OJ rats following partial hepatectomy.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Animals and experimental model of OJ</title>
<p>A total of 216 male Sprague-Dawley rats (age, 6&#x2013;8 weeks; weight, 200&#x2013;220 g), were obtained from the Experimental Animal Center of the Academy of Military Medical Science (Beijing, China). Animals were fed standard chow with water ad libitum and kept at 24&#x00B0;C and 40&#x0025; humidity with a 12 h light/dark cycle. OJ was induced by ligation of the common bile duct (CBD). To ensure the accuracy of the procedure, an operating microscope for small animal surgery was used (GX.SS.22-3, Binocular Operation Microscope; Shanghai Medical Optical Instruments Factory Co., Ltd, Shanghai, China). The current study was conducted in accordance with the guidelines set by the Guide for the Care and Use of Laboratory Animals (<xref rid="b16-etm-0-0-6402" ref-type="bibr">16</xref>) and was approved by the Ethical and Research Committee of the Chinese PLA Medical School (Beijing, China).</p>
<p>Prior to surgery, rats were fasted overnight with free access to water. Anesthesia was performed by isoflurane/oxygen inhalation (4&#x0025; isoflurane for induction, 1.5&#x0025; for maintenance of anesthesia). Hair on the abdomen of the rats was removed and an upper midline abdominal incision of ~3 cm was made following sterilization. The CBD was exposed and two 8-0 monofilament, non-absorbable nylon sutures (Shanghai Pudong Jinhuan Medical Products Co., Ltd, Shanghai, China) were placed under the bile duct between branches and anastomoses of CBD and pancreas. The sutures were ligated and the CBD between the two sutures was dissected. The abdominal wall was closed with a continuous suture. A second surgery was performed on rats with OJ following 7 days (<xref rid="b17-etm-0-0-6402" ref-type="bibr">17</xref>).</p>
</sec>
<sec>
<title>Experimental groups</title>
<p>Rats with OJ were randomly assigned into three groups: C group, sham operation/control group; OPT group, rats with OPT, including portal vein and hepatic artery; and OPV group, rats with OPV and preservation of the hepatic artery. The duration of occlusion was set to 15, 20, 30, 40, 50 and 60 min, and the 7-day survival rate following the second surgery was investigated in the OPT and OPV group (n=10 for each time point in each group, total n=120). The duration of occlusion was set to 30 min for liver injury and liver regeneration studies, and the sample time points were at 6, 24, 72 h and 7 days post hepatectomy (n=24 for C group, n=24 for OPV group and n=36 for OPT group). A total of 12 rats were used for the measurement of liver blood flow.</p>
</sec>
<sec>
<title>Surgical procedures for partial liver ischemia and hepatectomy in rats with OJ</title>
<p>After a total of 7 days following the surgery inducing OJ in rats, a second surgery was performed. The procedure combined biliary recanalization and partial liver ischemia under portal blood bypass through the caudate lobe (<xref rid="b14-etm-0-0-6402" ref-type="bibr">14</xref>) and a partial hepatectomy was performed in all rats. Rats with OJ were anesthetized as described above. The abdomen was entered through the incision of the previous procedure and dilated CBDs were isolated. A cannula (8&#x00D7;0.8 mm) was inserted into the duodenal side of the original bile duct and fixed. The second tip of the cannula was inserted into the dilated CBD and fixed.</p>
<p>When the recanalization of the bile duct was completed, the left and median liver lobes, which were resected in following steps, were ligated with 3-0 silk sutures. The pedicle, for the OPT group, or the portal vein, for the OPV group, of the right liver lobe was dissected and clamped with a microvascular clamp. In the C group, the pedicle was dissected but not clamped. The clamping was maintained for 15&#x2013;60 min. During ischemia, the abdomen was covered with plastic film to prevent evaporation of body fluids. Following occlusion, clamps were removed and liver reperfusion was initiated. The left, median and caudate lobes were resected and the abdomen was closed with 3-0 sutures. Following surgery, all rats were provided with rodent chow and water <italic>ad libitum</italic> until 6, 24, 72 h and 7 days post hepatectomy.</p>
</sec>
<sec>
<title>Sample collection</title>
<p>Serum and liver tissue samples were collected at 6, 24, 72 h and 7 days following partial hepatectomy (n=6 for each time point of each group). Serum samples from rats with OJ that did not undergo the second surgery were also collected for comparison (n=6). All rats were anesthetized as mentioned above and 5 ml blood was obtained from the inferior vena cava for serum testing. Then &#x2265;2 ml blood was drawn to sacrifice the rats weighing 200&#x2013;220 g by exsanguination. The liver were resected and weighted. The blood samples were centrifuged at 2,500 &#x00D7; g at 4&#x00B0;C for 15 min. The supernatant was stored at &#x2212;80&#x00B0;C for serum tests. Tissue samples that were taken from the remnant liver were cut into two pieces. One piece was immediately frozen in liquid nitrogen and stored at &#x2212;80&#x00B0;C for detection of gene and protein expression, the other piece was further sliced and fixed at 4&#x00B0;C for 24 h with 10&#x0025; formaldehyde in 0.1 M phosphate buffer (pH 7.4) for histopathological study.</p>
</sec>
<sec>
<title>Measurement of blood flow of the hepatic artery and portal vein</title>
<p>A total of 6 normal and 6 rats with OJ were paired according to body weight. Blood flow of the hepatic artery (HAF) and portal vein (PVF) was measured using the Transonic T206 Flow Meter (Transonic Systems Inc., Ithaca, NY, USA) during the second surgery. Following anesthesia and laparotomy, the common portal pedicle of the liver was dissected and a suitable probe was placed around the hepatic artery and portal vein. Blood flow was monitored for 1 min.</p>
</sec>
<sec>
<title>Measurement of microvascular liver blood flow (LBF) using laser speckle contrast imaging</title>
<p>Microvascular LBF in rats with OJ was assessed using laser speckle contrast imaging (moorFLPI-2 Full-Field Laser Perfusion Imager; Moor Instruments, Axminster, UK) during the second operation. Following PVF and HAF measurements, LBF of the whole liver was measured as previously described (<xref rid="b18-etm-0-0-6402" ref-type="bibr">18</xref>). Following ligation of the left and median liver lobes and clamping of the pedicle for the OPT group, or the portal vein for the OPV group, of the right liver lobe, the LBF of the right liver lobe was measured 5 min post-clamping. The sampling frequency was 21 images/sec and the image acquisition rate was 1 frame/sec in the normal resolution mode. The duration of recording was 15 sec. MoorFLPI-2 Review (version 4.0; Moor Instruments) was used to analyze the images and quantify the perfusion in arbitrary laser speckle perfusion units (LSPU).</p>
</sec>
<sec>
<title>Liver function test</title>
<p>Serum levels of alanine transaminase (ALT) and direct bilirubin (DBIL) were used as general markers of liver injury, which was measured with a serum analyzer (Cobas-Mira Plus; Roche Diagnostics GmbH, Mannheim, Germany).</p>
</sec>
<sec>
<title>Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title>
<p>Total RNA was extracted from frozen liver tissues using the RNA Simple Total RNA kit (Tiangen Biotech Co., Ltd., Beijing, China) according to the manufacturer&#x0027;s protocol. RNA (4 &#x00B5;g) was reverse transcribed using the RevertAid First Strand cDNA Synthesis kit and Oligo-dT primers (Thermo Fisher Scientific, Inc., Waltham, MA, USA). qPCR was performed with the SYBR Premix Ex Taq II (Takara Bio, Inc., Otsu, Japan) and the StepOnePlus Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.). Primers used were as follows: Tumor necrosis factor (TNF)-&#x03B1; forward, 5&#x2032;-AAATGGGCTCCCTCTCATCAGTTC-3&#x2032; and reverse, 5&#x2032;-TCTGCTTGGTGGTTTGCTACGAC-3&#x2032;; interleukin (IL)-1&#x03B2; forward, 5&#x2032;-CACCTCTCAAGCAGAGCACAG-3&#x2032; and reverse, 5&#x2032;-GGGTTCCATGGTGAAGTCAAC-3&#x2032;; hypoxanthine phosphoribosyltransferase (HPRT) forward, 5&#x2032;-GCTGAAGATTTGGAAAAGGTG-3&#x2032; and reverse, 5&#x2032;-AATCCAGCAGGTCAGCAAAG-3&#x2032;. The relative gene expression was normalized to HPRT. Values were calculated using the 2<sup>&#x2212;</sup>&#x0394;&#x0394;<sup>Cq</sup> method as previously described and expressed as fold change vs. normal rat (<xref rid="b19-etm-0-0-6402" ref-type="bibr">19</xref>).</p>
</sec>
<sec>
<title>Histological assessment and Ki-67 immunohistochemistry</title>
<p>Formalin-fixed tissues were embedded in paraffin and 5-&#x00B5;m sections were cut. Sections were stained for 3 min with hematoxylin and 2 min with eosin at room temperature for histological examination using a light microscope (magnification, &#x00D7;400). For immunohistochemistry, sections were incubated with a mouse anti-Ki-67 monoclonal antibody (1:50; cat. no. 550609; BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturer&#x0027;s protocol. Samples were counterstained with hematoxylin for 2 min at room temperature. The percentage of Ki-67-positive hepatocytes was determined in ten random visual fields using a light microscope (Leica Microsystems GmbH, Wetzlar, Germany) at magnification, &#x00D7;400 and the Ki-67 labeling index. All histological analyses were performed in a blinded manner with respect to the experimental groups.</p>
</sec>
<sec>
<title>Evaluation of liver regeneration following hepatectomy</title>
<p>Liver regeneration was evaluated using the rate of regeneration following hepatectomy of rats with OJ. Rate of regeneration=actual remnant liver weight at test point/W &#x00D7;100&#x0025;, where W represents the weight of the whole liver prior to hepatectomy. W was calculated as weight of the resected liver/76&#x0025; (the weight of the resected liver lobes account for 76&#x0025; of the whole liver) (<xref rid="b20-etm-0-0-6402" ref-type="bibr">20</xref>).</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>Frozen liver samples were homogenized in radioimmunoprecipitation assay buffer (Cell Signaling Technology, Inc., Danvers, MA, USA) supplemented with 1 mM phenyl methane sulfonyl fluoride and 1&#x00D7; phosphatase inhibitor. Homogenates were centrifuged at 10,000 &#x00D7; g for 10 min at 4&#x00B0;C. Supernatants were collected and protein concentrations were determined using the bicinchoninic acid method. Samples containing 50 &#x00B5;g of protein were separated on 10&#x0025; SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. Membranes were blocked with 5&#x0025; skimmed milk for 1 h at room temperature and incubated overnight at 4&#x00B0;C with primary antibodies: A mouse monoclonal antibody of anti-proliferating cell nuclear antigen (PCNA; 1:200; cat. no. sc-56; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), rabbit anti-caspase-3 (Asp175) (5A1E) monoclonal antibody (cat. no. 9664) and rabbit anti-caspase-9 (Asp353) polyclonal antibody (cat. no. 9507) (both 1:1,000; Cell Signaling Technology, Inc.). Following, membranes were incubated with horseradish peroxidase-conjugated goat anti-mouse (sc-2005) or goat anti-rabbit (sc-2004) secondary antibodies (1:2,000; Santa Cruz Biotechnology, Inc.) for 1 h at room temperature. Blots were developed with Super-Signal chemiluminescent substrate (cat. no. 34580; Thermo Fisher Scientific, Inc.). Blots were analyzed against mouse anti-GAPDH monoclonal antibodies (1:2,000; cat. no. KM9002T; Sungene Biotech Co., Ltd., Tianjin, China) expression, which was used as loading control.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data are expressed as the mean &#x00B1; standard deviation. Student&#x0027;s t-test was used for the comparison of two groups and one-way ANOVA with Student-Newman-Keuls test was used for the comparison of three groups. SPSS (version 17.0; SPSS, Inc., Chicago, IL, USA) was used for analyses. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Preservation of hepatic artery flow during liver blood inflow control extends the duration of liver ischemia in rats with OJ</title>
<p>All rats with OJ survived until the second surgical procedure. The dilated CBDs with a diameter of 8&#x2013;10 mm were visible during the second laparotomy. To assess the tolerance of rats with OJ to liver ischemia and hepatectomy, the safe limit for the duration of liver ischemia in rats with OJ that underwent OPT and OPV was investigated. In the OPT group, the 7-day survival rate decreased when the occlusion time was &#x003E;20 min (<xref rid="f1-etm-0-0-6402" ref-type="fig">Fig. 1</xref>). The safe limit for the duration of liver ischemia for the OPV group was extended to 40 min without affecting the survival rate. At an occlusion time of 50 min, the 7-day survival rate decreased to 90&#x0025; (9/10) in the OPV group and 0&#x0025; (0/10) in the OPT group. The 7-day survival rate of the OPV group was significantly increased compared with the OPT group at 40, 50 and 60 min of occlusion, respectively (P&#x003C;0.05; <xref rid="f1-etm-0-0-6402" ref-type="fig">Fig. 1</xref>). Determined safe limits for the duration of liver ischemia were 20 and 40 min for the OPT and OPV group, respectively. OPV, with preserved HAF in rats with OJ and partial hepatectomy, markedly prolonged the duration of liver ischemia during hepatectomy.</p>
</sec>
<sec>
<title>Hepatic hemodynamic changes in rats with OJ and liver ischemia</title>
<p>Liver PVF and HAF in rats with OJ were measured with an ultrasonic flow meter and compared with those of normal rats. PVF decreased significantly from 13.83&#x00B1;1.60 to 8.17&#x00B1;0.75 ml/min in rats with OJ compared to the control (P&#x003C;0.05) and HAF increased significantly from 1.10&#x00B1;0.14 to 1.98&#x00B1;0.38 ml/min in rats with OJ compared with the control (P&#x003C;0.05; <xref rid="f2-etm-0-0-6402" ref-type="fig">Fig. 2A</xref>). As HAF was low compared with PVF, the total liver blood inflow was decreased 7 days following induction of OJ.</p>
<p>During the portal blood occlusion prior to hepatectomy, LBF of the right liver lobe was measured with a laser speckle contrast imager. LBF of the control group was 529.53&#x00B1;91.55 LSPU (<xref rid="f2-etm-0-0-6402" ref-type="fig">Fig. 2B</xref>). Following portal occlusion, LBF significantly decreased to 136.89&#x00B1;32.32 LSPU for the OPT and 183.99&#x00B1;49.25 LSPU for the OPV group (P&#x003C;0.05). OPT and OPV significantly reduced the perfusion of liver microcirculation, with OPT being more effective compared with OPV (P&#x003C;0.05).</p>
</sec>
<sec>
<title>Effects of varying hepatic blood inflow occlusions on hepatic biochemical markers and expression of proinflammatory cytokine genes</title>
<p>ALT and DBIL levels of rats with OJ prior to the second surgery were 112.6&#x00B1;16.78 IU/l and 158.2&#x00B1;11.38 &#x00B5;mol/l, respectively. Following biliary drainage, portal occlusion and hepatectomy, ALT levels in rats with OJ increased, with the value for the OPT group significantly higher compared with the OPV and control groups at 6 and 24 h of reperfusion (P&#x003C;0.05; <xref rid="f3-etm-0-0-6402" ref-type="fig">Fig. 3A</xref>). At 24 h of reperfusion, the ALT level in the OPV group was significantly higher compared with the control group (P&#x003C;0.05). Due to the recovery of biliary drainage, DBIL levels in all rats decreased following the second operation, with the value for the OPT group significantly higher compared with the OPV and control groups at 6 h of reperfusion (P&#x003C;0.05; <xref rid="f3-etm-0-0-6402" ref-type="fig">Fig. 3B</xref>). At days 3 and 7 following hepatectomy, ALT and DBIL levels of all rats had decreased and no significant difference was observed between the groups. Rats in the OPT group suffered the most severe liver I/R injury among the three groups and OPV significantly reduced I/R-induced liver injury compared with the OPT method.</p>
<p>The current study assessed mRNA expression of the proinflammatory cytokines IL-1&#x03B2; and TNF-&#x03B1; (<xref rid="f3-etm-0-0-6402" ref-type="fig">Fig. 3C and D</xref>) in the remnant liver tissue using RT-qPCR. mRNA expression of IL-1&#x03B2; and TNF-&#x03B1; was significantly upregulated in the OPT group compared with the control and OPV groups at 6 and 24 h following I/R and hepatectomy (P&#x003C;0.05). The remnant liver in the control and OPV groups expressed similar levels of IL-1&#x03B2; and TNF-&#x03B1; mRNA at all of the time points. The data indicated that OPT induced a more severe inflammatory response and damage compared with OPV.</p>
</sec>
<sec>
<title>Pathological changes in the liver of rats with OJ following varying methods of portal occlusion and partial hepatectomy</title>
<p>Hepatic pathological changes in rats with OJ in the C, OPT and OPV groups were assessed at 6, 24 and 72 h and 7 days following different portal occlusion procedures and hepatectomy (<xref rid="f4-etm-0-0-6402" ref-type="fig">Fig. 4</xref>). Proliferative encysted cholangioles were observed in all groups, with prevalence at 6 and 24 h following the second surgical procedure. In addition, marked hepatocyte necrosis was detected in the OPT group with many neutrophils invading into the necrotic area at 6 and 24 h post hepatectomy. The necrotic area was enlarged at 72 h following the second surgical procedure. No necrotic area was observed in the C group and hepatocyte necrosis in the OPV group was minimal when compared with the OPT group. OPV was effective in preventing hepatocytic necrosis in rats with OJ, I/R and partial hepatectomy.</p>
</sec>
<sec>
<title>Liver regeneration in rats with OJ that underwent partial hepatectomy and varying portal occlusion procedures</title>
<p>Regeneration of the remnant liver following different intraoperative hepatic blood inflow occlusion procedures and partial hepatectomy were evaluated on days 3 and 7 following I/R and hepatectomy. Rates of liver regeneration on day 3 post-hepatectomy of C, OPV and OPT groups were 69.27&#x00B1;4.97, 66.18&#x00B1;4.43 and 59.70&#x00B1;5.03&#x0025;, respectively (<xref rid="f5-etm-0-0-6402" ref-type="fig">Fig. 5A</xref>). The rate of hepatic regeneration of the OPT group was significantly lower compared with the C and OPV groups (P&#x003C;0.05), indicating that total hepatic pedicle clamping for 30 min prior to hepatectomy inhibited liver regeneration. Preservation of HAF during hepatic blood inflow occlusion in the OPV group did not significantly reduce liver regeneration compared with the control group. On day 7 following the second surgical procedure, rates of liver regeneration of C, OPV and OPT reached 96.17&#x00B1;3.84, 94.23&#x00B1;5.44 and 91.33&#x00B1;9.29&#x0025;, respectively. No statistical differences were detected among the groups.</p>
<p>In order to further characterize the liver regenerative response, expression of Ki-67 is indicated as a brown nucleus in immunostained tissue sections, a nuclear antigen that is associated with hepatocyte proliferation, was assessed in remnant liver tissues. On day 3 post-operation, Ki-67 labeling indices of the OPT group (26.68&#x00B1;3.27&#x0025;) were significantly reduced compared with the C group (38.96&#x00B1;4.14&#x0025;) and the OPV group (31.94&#x00B1;4.38&#x0025;) (P&#x003C;0.05; <xref rid="f5-etm-0-0-6402" ref-type="fig">Fig. 5A</xref>) with the OPV group also lower than the C group (P&#x003C;0.05; <xref rid="f5-etm-0-0-6402" ref-type="fig">Fig. 5B and C</xref>). On day 7 following hepatectomy, Ki-67 expression was substantially decreased and no significant differences were detected among the groups (<xref rid="f5-etm-0-0-6402" ref-type="fig">Fig. 5B and C</xref>).</p>
</sec>
<sec>
<title>Effects of varying liver blood inflow occlusion procedures on hepatocyte proliferation and apoptosis</title>
<p>To further assess the liver regenerative capacity of rats with OJ following hepatectomy with varying liver blood inflow occlusive methods, PCNA, caspase-3 and 9 expression was determined by western blotting (<xref rid="f6-etm-0-0-6402" ref-type="fig">Fig. 6</xref>). PCNA is a marker that is associated with hepatocyte proliferation and caspase-3 and &#x2212;9 are associated with hepatocyte apoptosis (<xref rid="b21-etm-0-0-6402" ref-type="bibr">21</xref>,<xref rid="b22-etm-0-0-6402" ref-type="bibr">22</xref>).</p>
<p>PCNA expression increased at 24 h following I/R and hepatectomy in all groups compared with the 6 h measurements. PCNA expression at 24 h in group C was markedly higher compared with OPT and OPV groups. PCNA expression in the OPV group was significantly increased compared with the OPT group at 24 and 72 h following hepatectomy (P&#x003C;0.05; <xref rid="f6-etm-0-0-6402" ref-type="fig">Fig. 6</xref>). The opposite pattern was detected for caspase-3 and 9 expression, where expression in the OPT group was higher compared with the OPV group at 6 and 24 h following I/R and hepatectomy (P&#x003C;0.05; <xref rid="f6-etm-0-0-6402" ref-type="fig">Fig. 6</xref>). The results demonstrated that OPV was effective in improving hepatocyte proliferation and reducing hepatocyte apoptosis in rats with OJ following hepatectomy.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The Pringle maneuver is frequently used in hepatectomy due to its effectiveness in reducing blood loss during operation (<xref rid="b4-etm-0-0-6402" ref-type="bibr">4</xref>,<xref rid="b6-etm-0-0-6402" ref-type="bibr">6</xref>,<xref rid="b7-etm-0-0-6402" ref-type="bibr">7</xref>). However, I/R injury is inevitable in patients that require massive hepatectomy or in those with poor liver function, including cirrhosis and jaundice (<xref rid="b5-etm-0-0-6402" ref-type="bibr">5</xref>,<xref rid="b7-etm-0-0-6402" ref-type="bibr">7</xref>). Several strategies, including intermittent Pringle maneuver, selective hemi-hepatic vascular occlusion and ischemic preconditioning, have been proposed to improve the tolerance of the remnant liver to I/R injury (<xref rid="b11-etm-0-0-6402" ref-type="bibr">11</xref>&#x2013;<xref rid="b13-etm-0-0-6402" ref-type="bibr">13</xref>,<xref rid="b23-etm-0-0-6402" ref-type="bibr">23</xref>). However, none of these methods has been accepted as an ideal technique that results in reductions in liver injury and blood loss. It has previously been reported that OPV and preservation of HAF can significantly reduce hepatic I/R injury without increasing the risk of blood loss (<xref rid="b14-etm-0-0-6402" ref-type="bibr">14</xref>). This new surgical procedure provides better liver cytoprotection compared with OPT. In a previous study with CCl<sub>4</sub>-induced cirrhotic rats, OPV alone was also demonstrated to be effective in decreasing liver injury (<xref rid="b24-etm-0-0-6402" ref-type="bibr">24</xref>).</p>
<p>OJ is frequently reported in hepatobiliary surgery. The risk of liver failure is greater in individuals with jaundice compared with those without, due to pathological changes in jaundice, including cholangitis and cholestatic liver injury (<xref rid="b25-etm-0-0-6402" ref-type="bibr">25</xref>,<xref rid="b26-etm-0-0-6402" ref-type="bibr">26</xref>). Therefore, the current study investigated effects of the OPV method for controlling liver blood inflow and reducing liver injury in rats with OJ and hepatectomy.</p>
<p>As is demonstrated in the present study, total LBF of rats with OJ was markedly decreased compared with the normal rats. Although HAF of the OJ rats was increased, total LBF of the hepatic artery and portal vein decreased due to a decrease in PVF. This hemodynamic change in the liver of rats with OJ may result from compressed and damaged terminal parts of the portal vein and the hepatic sinusoid, which was due to the swelling of the OJ (<xref rid="b26-etm-0-0-6402" ref-type="bibr">26</xref>). This may account for the observation that rats with OJ have a decreased tolerance for hepatic portal occlusion. Following portal occlusion, LBF decreased significantly in both OPT and OPV groups. In a previous study it was demonstrated that the preservation of the hepatic artery when performing OPV may reduce I/R injury by supplying more oxygen to the liver and without markedly increasing blood loss compared with the Pringle maneuver in normal rats (<xref rid="b14-etm-0-0-6402" ref-type="bibr">14</xref>).</p>
<p>To the best of our knowledge, the present study is the first to determine the safe limit for the duration of liver ischemia as 20 min for the OPT and 40 min for the OPV method in rats with OJ. In addition, prolonging the occlusion time to 50 min significantly decreased the 7-day survival rate of the OPV group compared with the OPT group. Following portal occlusion and hepatectomy, ALT levels in the OPT group significantly increased and peaked at 6 and 24 h post-operation. ALT levels in the OPV and control groups were similar, which was consistent with the hepatic histological changes that were observed.</p>
<p>In order to further investigate the molecular changes in the liver following hepatectomy with OJ and portal blood occlusion, TNF-&#x03B1; and IL-1&#x03B2; expression in the remnant liver were analyzed. It was revealed that TNF-&#x03B1; and IL-1&#x03B2; mRNA expression in the OPT group was significantly higher compared with the control and OPV groups. The results demonstrated that preserving HAF may significantly reduce the inflammatory response compared with the OPT method, which is generally produced by I/R-activated inflammatory cells (<xref rid="b27-etm-0-0-6402" ref-type="bibr">27</xref>). In a previous study, it was demonstrated that liver tissue malondialdehyde values were significantly lower and Na<sup>&#x002B;</sup>-K<sup>&#x002B;</sup>-ATPase activity was significantly higher in the OPV group compared with the OPT group (<xref rid="b14-etm-0-0-6402" ref-type="bibr">14</xref>). An imbalance between the expression of genes that are involved in vasoconstriction and vasodilation was also observed in the OPT group, but not in the OPV group (<xref rid="b28-etm-0-0-6402" ref-type="bibr">28</xref>). Preserving low liver blood perfusion using the OPV method during liver surgery may be very effective for preventing hepatic microcirculatory dysfunction and hepatocyte injury.</p>
<p>When evaluating the advantages and disadvantages of a method for portal occlusion, the effect on hepatic regeneration is a vital factor. Hepatobiliary surgeons may select a method for occlusion that improves the liver regenerative ability. Following portal blood occlusion and hepatectomy of the same volumes of tissues, hepatic regeneration of the OPV group was significantly improved compared with the OPT group. At day 3 post-occlusion and hepatectomy, rates of liver regeneration and Ki-67 labeling indices of the OPV group were significantly higher compared with the OPT group. The PCNA level in the OPV group was higher compared with the OPT group according to western blot results. As indicated by the results presented in the current study, OPV improved the time of liver regeneration in rats with OJ compared with the OPT group. Combined with findings from laser speckle contrast imaging, low perfusion of oxygen in the hepatic artery blood and reduced damage in the OPV group may be key factors for the observed improvements in liver regeneration.</p>
<p>Overall, preserving HAF during portal triad blood occlusion may significantly reduce I/R injury and improve liver regeneration in rats with OJ that underwent partial hepatectomy compared with the Pringle maneuver, which was performed in the OPT group. The findings may provide guidance for future clinical studies. It may decrease the risk of liver failure following major hepatectomy, which is on occasion inevitable and potentially fatal when the duration of hepatic inflow occlusion is prolonged and resection of large volumes of liver tissue is necessary in order to clear niduses, particularly in patients with jaundice that present with hilar cholangiocarcinoma (<xref rid="b29-etm-0-0-6402" ref-type="bibr">29</xref>). A limitation of the OPV method in clinical application is the need to isolate the portal vein for occlusion by dissociating the pedicle of Glisson&#x0027;s capsule. In addition, auxiliary measures, including intraoperative low central venous pressure and appliance of ligature, may be used at the same time to reduce the blood loss in the application of OPV method in OJ patients who need a hepatectomy.</p>
<p>In conclusion, to the best of our knowledge, this is the first study on preserving HAF during portal triad blood clamping in the liver of rats with OJ. The OPV method resulted in less damage to the liver and it may facilitate improved liver regeneration. It may increase the current limits on the duration of portal blood occlusion. The OPV method may describe a novel technique of choice for controlling hepatic blood inflow in liver surgery, particularly in patients with complex jaundice cases, due to its simplicity and as it may be safer compared with the Pringle maneuver.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>This work was supported by the Project of the National Natural Science Foundation of China (grant no. 81271738) and the National Key Technology R&#x0026;D Program of China (grant no. 2012BAI06B01).</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>All data generated or analyzed during this study are included in this published article.</p>
</sec>
<sec>
<title>Authors&#x0027; contribution</title>
<p>ZK contributed to the animal experiments, data collection and analysis. JJH contributed to the interpretation of the data, writing and editing the article. XLG and KP contributed to data analysis and histopathology examinations. JHD contributed to conception and design. CHL contributed to conception, writing, critical revision and editing of the article.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The current study was approved by the Ethical and Research Committee of the Chinese PLA Medical School (Beijing, China).</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-6402"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandi</surname><given-names>G</given-names></name><name><surname>Venturi</surname><given-names>M</given-names></name><name><surname>Pantaleo</surname><given-names>MA</given-names></name><name><surname>Ercolani</surname><given-names>G</given-names></name></person-group><article-title>GICO: Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center</article-title><source>Dig Liver Dis</source><volume>48</volume><fpage>231</fpage><lpage>241</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.dld.2015.11.017</pub-id><pub-id pub-id-type="pmid">26769568</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-6402"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uppal</surname><given-names>DS</given-names></name><name><surname>Wang</surname><given-names>AY</given-names></name></person-group><article-title>Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma</article-title><source>World J Gastrointest Endosc</source><volume>7</volume><fpage>675</fpage><lpage>687</lpage><year>2015</year><pub-id pub-id-type="doi">10.4253/wjge.v7.i7.675</pub-id><pub-id pub-id-type="pmid">26140095</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-6402"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YI</given-names></name></person-group><article-title>Ischemia-reperfusion injury of the human liver during hepatic resection</article-title><source>J Hepatobiliary Pancreat Surg</source><volume>10</volume><fpage>195</fpage><lpage>199</lpage><year>2003</year><pub-id pub-id-type="doi">10.1007/s00534-002-0730-x</pub-id><pub-id pub-id-type="pmid">14605975</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-6402"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Riel</surname><given-names>WG</given-names></name><name><surname>van Golen</surname><given-names>RF</given-names></name><name><surname>Reiniers</surname><given-names>MJ</given-names></name><name><surname>Heger</surname><given-names>M</given-names></name><name><surname>van Gulik</surname><given-names>TM</given-names></name></person-group><article-title>How much ischemia can the liver tolerate during resection?</article-title><source>Hepatobiliary Surg Nutr</source><volume>5</volume><fpage>58</fpage><lpage>71</lpage><year>2016</year><pub-id pub-id-type="pmid">26904558</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-6402"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celotti</surname><given-names>A</given-names></name><name><surname>Solaini</surname><given-names>L</given-names></name><name><surname>Montori</surname><given-names>G</given-names></name><name><surname>Coccolini</surname><given-names>F</given-names></name><name><surname>Tognali</surname><given-names>D</given-names></name><name><surname>Baiocchi</surname><given-names>G</given-names></name></person-group><article-title>Preoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta-analysis</article-title><source>Eur J Surg Oncol</source><volume>43</volume><fpage>1628</fpage><lpage>1635</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.ejso.2017.04.001</pub-id><pub-id pub-id-type="pmid">28477976</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-6402"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>K</given-names></name><name><surname>Fan</surname><given-names>ST</given-names></name><name><surname>Ng</surname><given-names>IO</given-names></name><name><surname>Lo</surname><given-names>CM</given-names></name><name><surname>Liu</surname><given-names>CL</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name></person-group><article-title>Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study</article-title><source>Ann Surg</source><volume>226</volume><fpage>704</fpage><lpage>711</lpage><year>1997</year><pub-id pub-id-type="doi">10.1097/00000658-199712000-00007</pub-id><pub-id pub-id-type="pmid">9409569</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-6402"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gulik</surname><given-names>TM</given-names></name><name><surname>de Graaf</surname><given-names>W</given-names></name><name><surname>Dinant</surname><given-names>S</given-names></name><name><surname>Busch</surname><given-names>OR</given-names></name><name><surname>Gouma</surname><given-names>DJ</given-names></name></person-group><article-title>Vascular occlusion techniques during liver resection</article-title><source>Dig Surg</source><volume>24</volume><fpage>274</fpage><lpage>281</lpage><year>2007</year><pub-id pub-id-type="doi">10.1159/000103658</pub-id><pub-id pub-id-type="pmid">17657152</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-6402"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>JS</given-names></name><name><surname>Guha</surname><given-names>IN</given-names></name><name><surname>Beckingham</surname><given-names>IJ</given-names></name><name><surname>Lobo</surname><given-names>DN</given-names></name></person-group><article-title>Prediction, prevention and management of postresection liver failure</article-title><source>Br J Surg</source><volume>98</volume><fpage>1188</fpage><lpage>1200</lpage><year>2011</year><pub-id pub-id-type="doi">10.1002/bjs.7630</pub-id><pub-id pub-id-type="pmid">21725970</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-6402"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hameed</surname><given-names>A</given-names></name><name><surname>Pang</surname><given-names>T</given-names></name><name><surname>Chiou</surname><given-names>J</given-names></name><name><surname>Pleass</surname><given-names>H</given-names></name><name><surname>Lam</surname><given-names>V</given-names></name><name><surname>Hollands</surname><given-names>M</given-names></name><name><surname>Johnston</surname><given-names>E</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><name><surname>Yuen</surname><given-names>L</given-names></name></person-group><article-title>Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma-a systematic review and meta-analysis</article-title><source>HPB (Oxford)</source><volume>18</volume><fpage>400</fpage><lpage>410</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.hpb.2016.03.002</pub-id><pub-id pub-id-type="pmid">27154803</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-6402"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blechacz</surname><given-names>B</given-names></name><name><surname>Komuta</surname><given-names>M</given-names></name><name><surname>Roskams</surname><given-names>T</given-names></name><name><surname>Gores</surname><given-names>GJ</given-names></name></person-group><article-title>Clinical diagnosis and staging of cholangiocarcinoma</article-title><source>Nat Rev Gastroenterol Hepatol</source><volume>8</volume><fpage>512</fpage><lpage>522</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/nrgastro.2011.131</pub-id><pub-id pub-id-type="pmid">21808282</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-6402"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Niu</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Outcome using selective hemihepatic vascular occlusion and Pringle maneuver for hepatic resection of liver cavernous hemangioma</article-title><source>World J Surg Oncol</source><volume>13</volume><fpage>267</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12957-015-0680-9</pub-id><pub-id pub-id-type="pmid">26338222</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-6402"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>L</given-names></name><name><surname>Meng</surname><given-names>WS</given-names></name><name><surname>Su</surname><given-names>BD</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Liang</surname><given-names>HF</given-names></name><name><surname>Chen</surname><given-names>YF</given-names></name><name><surname>Chen</surname><given-names>XP</given-names></name></person-group><article-title>Step-by-step vascular control for extracapsular resection of complex giant liver hemangioma involving the inferior vena cava</article-title><source>Am Surg</source><volume>80</volume><fpage>15</fpage><lpage>20</lpage><year>2014</year><pub-id pub-id-type="pmid">24401502</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-6402"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurusamy</surname><given-names>KS</given-names></name><name><surname>Kumar</surname><given-names>Y</given-names></name><name><surname>Pamecha</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>D</given-names></name><name><surname>Davidson</surname><given-names>BR</given-names></name></person-group><article-title>Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion</article-title><source>Cochrane Database Syst Rev: CD007629</source><year>2009</year><pub-id pub-id-type="doi">10.1002/14651858.CD007530</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-6402"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Zhang</surname><given-names>AQ</given-names></name><name><surname>Yang</surname><given-names>SZ</given-names></name><name><surname>Zhang</surname><given-names>WZ</given-names></name><name><surname>Dong</surname><given-names>JH</given-names></name></person-group><article-title>Preserving hepatic artery flow during portal triad blood inflow occlusion reduces liver ischemia-reperfusion injury in rats</article-title><source>J Surg Res</source><volume>174</volume><fpage>150</fpage><lpage>156</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.jss.2010.11.913</pub-id><pub-id pub-id-type="pmid">21316704</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-6402"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>E</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name><name><surname>Nagino</surname><given-names>M</given-names></name><name><surname>Nimura</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name></person-group><article-title>DNA polymerases and Ki-67 nuclear antigen are induced in correlation with the resected mass of rat liver up to 90&#x0025;</article-title><source>Langenbecks Arch Surg</source><volume>385</volume><fpage>135</fpage><lpage>142</lpage><year>2000</year><pub-id pub-id-type="doi">10.1007/s004230050256</pub-id><pub-id pub-id-type="pmid">10796052</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-6402"><label>16</label><element-citation publication-type="book"><source>Institute for Laboratory Animal Research: Guide for the care and use of laboratory animals</source><edition>8th (ed.)</edition><publisher-loc>Washington (DC)</publisher-loc><publisher-name>National Academies Press (US)</publisher-name><year>2011</year></element-citation></ref>
<ref id="b17-etm-0-0-6402"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Zhang</surname><given-names>AQ</given-names></name><name><surname>Kong</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>WQ</given-names></name><name><surname>Dong</surname><given-names>JH</given-names></name></person-group><article-title>A simple rat model of in situ reversible obstructive jaundice in situ reversible obstructive jaundice model</article-title><source>Ann Surg Treat Res</source><volume>92</volume><fpage>389</fpage><lpage>395</lpage><year>2017</year><pub-id pub-id-type="doi">10.4174/astr.2017.92.6.389</pub-id><pub-id pub-id-type="pmid">28580342</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-6402"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>HD</given-names></name><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Ge</surname><given-names>XL</given-names></name><name><surname>Pan</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>AQ</given-names></name><name><surname>Dong</surname><given-names>JH</given-names></name></person-group><article-title>The monitoring of microvascular liver blood flow changes during ischemia and reperfusion using laser speckle contrast imaging</article-title><source>Microvasc Res</source><volume>94</volume><fpage>28</fpage><lpage>35</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.mvr.2014.04.010</pub-id><pub-id pub-id-type="pmid">24799282</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-6402"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-6402"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>PF</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Zhang</surname><given-names>AQ</given-names></name><name><surname>Cai</surname><given-names>SW</given-names></name><name><surname>Dong</surname><given-names>JH</given-names></name></person-group><article-title>Preserving hepatic artery flow during portal triad blood inflow occlusion improves remnant liver regeneration in rats after partial hepatectomy</article-title><source>J Surg Res</source><volume>181</volume><fpage>329</fpage><lpage>336</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.jss.2012.07.028</pub-id><pub-id pub-id-type="pmid">22878147</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-6402"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paranjpe</surname><given-names>S</given-names></name><name><surname>Bowen</surname><given-names>WC</given-names></name><name><surname>Bell</surname><given-names>AW</given-names></name><name><surname>Nejak-Bowen</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>JH</given-names></name><name><surname>Michalopoulos</surname><given-names>GK</given-names></name></person-group><article-title>Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference</article-title><source>Hepatology</source><volume>45</volume><fpage>1471</fpage><lpage>1477</lpage><year>2007</year><pub-id pub-id-type="doi">10.1002/hep.21570</pub-id><pub-id pub-id-type="pmid">17427161</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-6402"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Ramshesh</surname><given-names>VK</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Currin</surname><given-names>RT</given-names></name><name><surname>Lemasters</surname><given-names>JJ</given-names></name><name><surname>Zhong</surname><given-names>Z</given-names></name></person-group><article-title>NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy</article-title><source>Transplantation</source><volume>91</volume><fpage>406</fpage><lpage>412</lpage><year>2011</year><pub-id pub-id-type="pmid">21131897</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-6402"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>SY</given-names></name><name><surname>Lau</surname><given-names>WY</given-names></name><name><surname>Li</surname><given-names>GG</given-names></name><name><surname>Tang</surname><given-names>QH</given-names></name><name><surname>Li</surname><given-names>AJ</given-names></name><name><surname>Pan</surname><given-names>ZY</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>MC</given-names></name><name><surname>Lai</surname><given-names>EC</given-names></name><name><surname>Zhou</surname><given-names>WP</given-names></name></person-group><article-title>A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy</article-title><source>Am J Surg</source><volume>201</volume><fpage>62</fpage><lpage>69</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.amjsurg.2009.09.029</pub-id><pub-id pub-id-type="pmid">20409520</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-6402"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Wang</surname><given-names>HD</given-names></name><name><surname>Xu</surname><given-names>WL</given-names></name><name><surname>Zhang</surname><given-names>AQ</given-names></name><name><surname>Dong</surname><given-names>JH</given-names></name></person-group><article-title>Portal vein clamping alone confers protection against hepatic ischemia-reperfusion injury via preserving hepatocyte function in cirrhotic rats</article-title><source>J Surg Res</source><volume>194</volume><fpage>139</fpage><lpage>146</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jss.2014.10.003</pub-id><pub-id pub-id-type="pmid">25481529</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-6402"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>Y</given-names></name><name><surname>Tsuchikawa</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Tamoto</surname><given-names>E</given-names></name><name><surname>Noji</surname><given-names>T</given-names></name><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Shichinohe</surname><given-names>T</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name></person-group><article-title>Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: A study of 229 patients at a single institution</article-title><source>HPB (Oxford)</source><volume>18</volume><fpage>735</fpage><lpage>741</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.hpb.2016.06.013</pub-id><pub-id pub-id-type="pmid">27593590</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-6402"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xin</surname><given-names>KY</given-names></name><name><surname>Yee</surname><given-names>LS</given-names></name><name><surname>Yong</surname><given-names>TT</given-names></name><name><surname>Fui</surname><given-names>AC</given-names></name></person-group><article-title>Obstructive jaundice due to intraductal tumour thrombus in recurrent hepatocellular carcinoma: What is the optimal therapeutic approach?</article-title><source>Hepatogastroenterology</source><volume>61</volume><fpage>1863</fpage><lpage>1866</lpage><year>2014</year><pub-id pub-id-type="pmid">25713879</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-6402"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanner</surname><given-names>GA</given-names></name><name><surname>Ertel</surname><given-names>W</given-names></name><name><surname>M&#x00FC;ller</surname><given-names>P</given-names></name><name><surname>H&#x00F6;fer</surname><given-names>Y</given-names></name><name><surname>Leiderer</surname><given-names>R</given-names></name><name><surname>Menger</surname><given-names>MD</given-names></name><name><surname>Messmer</surname><given-names>K</given-names></name></person-group><article-title>Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation</article-title><source>Shock</source><volume>5</volume><fpage>34</fpage><lpage>40</lpage><year>1996</year><pub-id pub-id-type="doi">10.1097/00024382-199601000-00008</pub-id><pub-id pub-id-type="pmid">8821101</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-6402"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>YW</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Yao</surname><given-names>LB</given-names></name><name><surname>Ge</surname><given-names>XL</given-names></name><name><surname>Pan</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>AQ</given-names></name><name><surname>Dong</surname><given-names>JH</given-names></name></person-group><article-title>Preserving low perfusion during surgical liver blood inflow control prevents hepatic microcirculatory dysfunction and irreversible hepatocyte injury in rats</article-title><source>Sci Rep</source><volume>5</volume><fpage>14406</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/srep14406</pub-id><pub-id pub-id-type="pmid">26400669</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-6402"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiggers</surname><given-names>JK</given-names></name><name><surname>Koerkamp</surname><given-names>Groot B</given-names></name><name><surname>Cieslak</surname><given-names>KP</given-names></name><name><surname>Doussot</surname><given-names>A</given-names></name><name><surname>van Klaveren</surname><given-names>D</given-names></name><name><surname>Allen</surname><given-names>PJ</given-names></name><name><surname>Besselink</surname><given-names>MG</given-names></name><name><surname>Busch</surname><given-names>OR</given-names></name><name><surname>D&#x0027;Angelica</surname><given-names>MI</given-names></name><name><surname>DeMatteo</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Postoperative mortality after liver resection for perihilar cholangiocarcinoma: Development of a risk score and importance of biliary drainage of the future liver remnant</article-title><source>J Am Coll Surg</source><volume>223</volume><issue>321&#x2013;331</issue><fpage>e1</fpage><year>2016</year><pub-id pub-id-type="pmid">27118710</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-6402" position="float">
<label>Figure 1.</label>
<caption><p>Comparison of the 7-day survival rate of rats with obstructive jaundice that underwent varying types of portal blood occlusion and 76&#x0025; hepatectomy. Survival rates were determined following varying occlusion times during the second surgery. n=10 at each time point for each group. &#x002A;P&#x003C;0.05 vs. OPT group. OPT, occlusion of the portal triad; OPV, occlusion of the portal vein and preservation of the hepatic artery.</p></caption>
<graphic xlink:href="etm-16-03-1910-g00.tif"/>
</fig>
<fig id="f2-etm-0-0-6402" position="float">
<label>Figure 2.</label>
<caption><p>Hepatic hemodynamic changes in rats with OJ. (A) Comparison of liver PVF and HAF in rats with OJ and normal rats by analysis using an ultrasonic flow meter. &#x002A;P&#x003C;0.05 vs. the Normal group. (B) Comparison of the microvascular LBF of rats with OJ during varying methods of portal blood control using a laser speckle contrast imager. <sup>#</sup>P&#x003C;0.05 vs. the C group; &#x002A;P&#x003C;0.05 vs. the OPT group. n=6 at each time point for each group. PVF, portal vein flow; HAF, hepatic artery flow; OJ, obstructive jaundice; LBF, liver blood flow; C, control without portal blood occlusion; OPT, occlusion of the portal triad; OPV, occlusion of the portal vein and preservation of the hepatic artery.</p></caption>
<graphic xlink:href="etm-16-03-1910-g01.tif"/>
</fig>
<fig id="f3-etm-0-0-6402" position="float">
<label>Figure 3.</label>
<caption><p>Biochemical markers and expression of proinflammatory cytokine genes. Detection of (A) plasma ALT and (B) DBIL and (C) IL-1&#x03B2; and (D) TNF-&#x03B1; mRNA expression over time in rats with obstructive jaundice that underwent varying intraoperative hepatic blood inflow occlusions and hepatectomy. n=6 at each time point for each group. <sup>#</sup>P&#x003C;0.05 vs. the C group; &#x002A;P&#x003C;0.05 vs. the OPT group. C, control without portal blood occlusion; OPT, occlusion of the portal triad; OPV, occlusion of the portal vein and preservation of the hepatic artery; ALT, alanine transaminase; DBIL, direct bilirubin; IL-1&#x03B2;, interleukin-1&#x03B2;; TNF-&#x03B1;, tumor necrosis factor-&#x03B1;.</p></caption>
<graphic xlink:href="etm-16-03-1910-g02.tif"/>
</fig>
<fig id="f4-etm-0-0-6402" position="float">
<label>Figure 4.</label>
<caption><p>Representative hematoxylin and eosin staining of the remnant liver of rats with obstructive jaundice that underwent varying intraoperative hepatic blood inflow occlusions at 6, 24 and 72 h and 7 days following liver ischemia-reperfusion and partial hepatectomy. Visualized using light microscopy (magnification, &#x00D7;400). C, control group without portal blood occlusion; OPT, occlusion of the portal triad; OPV, occlusion of the portal vein and preservation of the hepatic artery.</p></caption>
<graphic xlink:href="etm-16-03-1910-g03.tif"/>
</fig>
<fig id="f5-etm-0-0-6402" position="float">
<label>Figure 5.</label>
<caption><p>Liver regeneration and Ki-67 expression in rats with obstructive jaundice that underwent varying intraoperative hepatic blood inflow occlusions on days 3 and 7 following ischemia-reperfusion and hepatectomy. (A) Rate of liver regeneration calculated using liver weight. (B) Ki-67 labeling index. (C) Representative light microscopy image of immunohistochemical staining of Ki-67 in liver sections (magnification, &#x00D7;400). <sup>#</sup>P&#x003C;0.05 vs. the C group; &#x002A;P&#x003C;0.05 vs. the OPV group. n=6 at each time point for each group. C, control group without portal blood occlusion; OPT, occlusion of the portal triad; OPV, occlusion of the portal vein and preservation of the hepatic artery.</p></caption>
<graphic xlink:href="etm-16-03-1910-g04.tif"/>
</fig>
<fig id="f6-etm-0-0-6402" position="float">
<label>Figure 6.</label>
<caption><p>Protein expression in the remnant liver of rats with obstructive jaundice that underwent different intraoperative hepatic blood inflow occlusions and hepatectomy. Western blot analysis of PCNA, caspase-3 and 9 expressions at (A) 6 h, (C) 24 h and (E) 72 h following hepatectomy. The quantified results of (B) PCNA, (D) caspase-3 and (F) caspase-9 are presented. <sup>#</sup>P&#x003C;0.05 vs. the C group; &#x002A;P&#x003C;0.05 vs. the OPT group. n=3 rats per group per time point. C, control group without portal blood occlusion; OPT, occlusion of the portal triad; OPV, occlusion of the portal vein and preservation of the hepatic artery; PCNA, proliferating cell nuclear antigen.</p></caption>
<graphic xlink:href="etm-16-03-1910-g05.tif"/>
</fig>
</floats-group>
</article>
